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The assessment of human exposure to occupational and environmental chemicals is a difficult and complex problem for toxicologists, industrial hygienists, and risk assessors alike who seek to evaluate and control factors relating to human health. Specifically, factors relating to the disposition and metabolism of these chemicals are important in determining target tissue dosimetry in relation to the specific physiological outcome. In the early 1980s, physiologically based pharmacokinetic (PBPK) modeling was applied to study the disposition and metabolism of environmental chemicals in mammalian systems (Andersen, 1981; Ramsey and Andersen, 1984; Andersen et al, 1987) . These models serve as valuable tools for integrating mechanistic pharmacokinetic information through their explicit description of important physiological and biochemical determinants of chemical disposition. As a result, PBPK models are well suited to perform the types of extrapolations employed in human health evaluation.
In spite of the potential of PBPK modeling for describing biological processes, PBPK models, in general, have been written to describe the behavior of a chemical in an "average" member of a population with neither an estimate of interindividual variability in the model input nor an evaluation of uncertainty in model output (e.g., Bungay et al, 1981; Ramsey and Andersen, 1984; Paustenbachefa/., 1988; Reitz et al, 1988; Corley et al, 1990; Leung et al, 1990; Travis et al, 1990; Leung, 1992; Kedderis et al, 1993; Corley et al, 1994; Luecke et al, 1994; Gray, 1995; Terry et al, 1995) . Large uncertainty in a sensitive model parameter may result in misleading estimates of target tissue dose that would not be uncovered using traditional deterministic models. In an occupational scenario, the application of PBPK models without distinct variability among model parameters may result in estimates of biological exposure indices (BEIs) that do not reflect a majority of the worker population (Thomas et al, 1996) .
Monte Carlo methods involve choosing parameter values using a random or stochastic selection scheme. A very large number of simulations are performed, for which the values of the output variable(s) are saved for later analysis. In doing so, the distribution of the model output, including its uncertainty, can be estimated. Although Monte Carlo simulation has been utilized to study the impact of interindividual variability on PBPK model output (Farrar et al, 1989; Portier and Kaplan, 1989; Bois et al, 1991b; Hetrick et al., 1991; Spear et al, 1991; Bois and Paxman, 1992; Clewell and Jarnot, 1994; Yang et al, 1995; Thomas et al, 1996) , no computational method has been presented which allows investigators to readily incorporate Monte Carlo simulation into PBPK models written in Advanced Continuous Simulation Language (ACSL).
The objective of this paper is to provide a versatile and simple computational method for incorporating Monte Carlo simulation into current PBPK models and allow researchers to estimate the uncertainty in model output without resorting to extensive additions to model code. For the purposes of this article, the definition of uncertainty will include both measurement error and inter-and intraindividual variation with respect to specific biological processes. In contrast, the definition of variability will be confined to only the variation within and among individuals. Although the principles of Monte Carlo simulation can be applied to any computer language, the method described herein is specific for the ACSL programming language due to its prevalence within the PBPK modeling community. An example of the application of Monte Carlo simulation used to calculate interindividual variability in metabolite concentrations from benzene exposure is provided. However, the example is not intended to be a comprehensive treatment of benzene pharmacokinetics. A detailed treatment of benzene disposition is available from a variety of other articles (Medinsky et al, 1989; Travis et al, 1990; Bois et al, 1991a,b; Bois and Paxman, 1992) .
MATERIALS AND METHODS
Computers and software packages. Parameter sampling routines and Monte Carlo simulation were performed using both the SimuSolv version 3.0 (Dow Chemical Co., Midland, MI) and ACSL/PC for Windows version 10.1 (Mitchell and Gauthier Associates, Inc., Concord, MA) software packages. Modeling exercises with SimuSolv were executed using an IBM RISC 6000 mainframe computer while ACSL/PC for Windows was operated on a Hewlett Packard Vectra VL2 4/66 (Hewlett Packard Co., Boise, ID). Statistical analyses were performed using the Minitab (version 7.2) software package (Minitab, Inc., State College, PA).
For the work described in this paper, the SimuSolv protocol was followed. Thus, run-time and system commands, as well as file names, will be different on other computer systems. Refer to the operating manual for specific changes.
General ACSL Mechanics and Programming.
The application of ACSL within the software packages consists of two distinct computer files:
(1) a model definition program or ACSL file; and (2) a run-time command or CMD file. The model definition program, written in ACSL, contains the mathematical (PBPK) model and is required in order to execute a simulation. In contrast, the run-time command file contains long or frequently used commands which can be invoked during dialog with SimuSolv or ACSL/PC for Windows. The presence of a CMD file, however, is not necessary to execute a simulation.
Parameter sampling program and algorithms. The first step necessary to run Monte Carlo simulation on a PBPK model is to create a separate model definition program or ACSL file to randomly sample model parameters. This program is used to generate a separate file which will be renamed as a CMD file and will eventually be used to run the PBPK model. Computer code for the parameter sampling program can be found in Appendix A, and a flow chart is provided to depict the processes (Fig. 1) .
The parameter sampling program used to generate the CMD file is a typical model definition program and consists of three segments: INITIAL, DYNAMIC, and TERMINAL. The variables used in this program are defined in Table 1 constants, PI2, which maintains a value of 2 TT, is required in generating random values of the desired probability distributions. A simulation counter (SIMS) is initialized to keep track of the number of simulations performed while the constant, NUMBER, defines the number of simulations desired. Finally, a communication interval (CINT) is established to define the number of repetitions per simulation.
The DYNAMIC segment contains a series of programming blocks each assigned to randomly sample a distinct model parameter (see Appendix A). A typical programming block consists of three statements: (1) defining variability (e.g., standard deviation) and central tendency (e.g., mean) of the model parameter; (2) commands to generate random numbers between 0 and 1 from uniform distributions; and (3) an algorithm that transforms the random numbers from the uniform distribution into the desired probability distribution based on the variability and central tendency. For example, a normal distribution is assigned to the blood flow in the liver as a percentage of cardiac output (QLC) (see Appendix A). A probability distribution based on the mean and standard deviation can be generated from the equation (Naylor et al., 1968) QLC = V-2 * ln(RND 1) * COS(PI2 * RND2) * a + fi, where RND1 and RND2 are random numbers between 0 and 1 from uniform distributions, PI2 is 2 w, and fi and a are the mean and standard deviation, respectively, for blood flow. A similar equation is used to generate lognormal probability distributions in parameters such as cardiac output (QCC) (Naylor et al., 1968) where RND1 and RND2 are random numbers between 0 and 1 from uniform distributions, PI2 is 2 n, and GM and GSD are the geometric mean and geometric standard deviation, respectively, for cardiac output. For those parameters that represent a fraction of blood flow, tissue volume, or metabolite formation, a series of "IF-THEN" statements were added to constrain the parameter to be less than 1 and greater than or equal to 0.01.
Once separate parameter sampling routines are written for model parameters, a final program block is created within the DYNAMIC segment which continuously writes the randomly sampled parameters into a data file (param.dat). Within this program block, a series of output statements (OPEN/ WRITE/FORMAT) are assembled for groups of parameters and constructed such that randomly sampled parameters are written in a run-time language or CMD format (see Appendix A). The final output statement includes the introduction of an ASCII character, $ (which specifies a new line), and a START command following the final model parameter which allows a new simulation to be initiated following the execution of each group of randomly sampled model parameters (see Appendix A). It should be noted that the names assigned to the sampled parameters must match the variable names in the PBPK model since the output of this file will be used to eventually execute the model. Finally, the last variable in the DYNAMIC section (TERMT) is set to end the program when the simulation counter (SIMS) is greater than or equal to the number of simulations desired (NUMBER).
The TERMINAL segment allows the execution of an output statement following the end of the random sampling routines. Specifically, a STOP command is added at the end of the data file to automatically terminate program execution and allow the Monte Carlo simulation of the PBPK model to be executed without attention from the user. This facilitates the use of the program and allows the program to operate in background mode.
Due to the programming characteristics of SimuSolv, the final output statement and the OPEN command are formatted to bypass the translator. This is done by the inclusion of two equal signs (==) followed by seven spaces prior to the command. However, the equal signs must be removed for the program to operate in ACSL/PC for Windows. The model definition program described above is translated and executed using ACSL to create a master operating file containing the randomly sampled model parameters and runtime commands. Although it is not necessary in SimuSolv, this file should be renamed to be compatible with the ACSL file containing the PBPK model (i.e., model.cmd to run model.acsl).
The output of the model definition program is provided in Appendix B; however, it should be noted that for simplicity of illustration, the output of the model definition program was limited to five sets of sampled parameters.
Modifying PBPK model for Monte Carlo simulation. The basic PBPK model can be modified for Monte Carlo simulation by the addition of a TERMINAL segment within the model definition program (see Appendix C). The TERMINAL segment consists of OPEN/WRITE/FORMAT commands to write the desired output variable(s) to a separate data file (output.-dat) following each simulation. As in the parameter sampling program, the OPEN command in SimuSolv must be preceded by two equal signs (==) and seven spaces which are not necessary in ACSL/PC for Windows. Once the PBPK model is modified, the master CMD file created by the parameter sampling program (i.e., rndnum.acsl) is used to run the modified PBPK model using the randomly sampled model parameters and run-time commands. The output variables are written to the data file following execution with each set of randomly sampled parameters. Statistical analysis of the Monte Carlo simulation results can be obtained by reading the output files into a commercial software package and calculating the appropriate statistics. An example of the output from Monte Carlo simulation is provided in Appendix D.
PBPK model structure. The basic physiological model structure for human inhalation exposure to benzene is described by Leung (1992) and Thomas et al. (1996) . The body is subdivided into five tissue groups consisting of the liver, lung, slowly perfused, rapidly perfused, and fat, while each compartment is represented by a mass balance differential equation which incorporates blood flows, partition coefficients, and tissue volumes. The concentration of the benzene in the blood leaving the lung is assumed to be in equilibrium with the concentration in alveolar air as determined by the blood:air partition coefficient. The chemical is distributed to all tissues and eliminated by metabolism in the liver, as well as by exhalation. Excretion of the primary metabolite (i.e., phenol) is assumed to occur through a first-order process (K c ) for which the fractional metabolite formation (F m ) for phenol is included. The mass balance equation for the liver describes metabolism in terms of a single saturable process. Specifically, the saturable process has a maximum metabolic rate, ^ (mg/hr), and a Michaelis constant, K m (mg/liter). A description of the mass balance differential equations used in the model is described, in detail, by Leung (1992) .
Physiological values used in the model are scaled as a function of body weight or cardiac output (Ramsey and Andersen, 1984; Gargas et al, 1986) . Cardiac output and alveolar ventilation are calculated as a direction function of body weight (Thomas et al, 1996) . Blood flows to the liver, richly perfused, slowly perfused, and fat are calculated as a percentage of cardiac output, while tissue volumes are calculated as a fraction of body weight. Metabolic and solubility parameters are used directly as model input and not scaled.
Chemical input to the model is set to the threshold limit value (TLV) concentration of benzene (i.e., 10 ppm) (ACGIH, 1994) . The model is constructed to simulate an 8-hr exposure.
Variability in model parameters.
A summary of the interindividual variability and distributions of model parameters for benzene is presented in Table 1 . The central tendencies for the model were obtained from Leung (1992) , while the distributions were acquired from Portier and Kaplan (1989) . The variabilities for the model parameters were obtained from a variety of published studies and are presented, in detail, by Thomas et al. (1996) . For purposes of keeping the example simple, intraindividual variability was not considered.
For model stability, as well as for practical reasons, alveolar ventilation is set equal to cardiac output, and the sum of the individual organ masses is constrained to be less than the total body mass. This is achieved by setting the volume of slowly perfused tissue equal to the difference between body mass and remaining tissues. A conservation of blood flow is accomplished by setting the flow to rapidly perfused tissues equal to the difference between cardiac output and flows to remaining compartments. Fractional parameters, such as blood flow to the tissues, were constrained to be less than 1 and greater than or equal to 0.01. A total of 1000 computer simulations are performed using the PBPK model for benzene. The total number of simulations should be high enough to fully characterize the output distribution as well as adequately sample the distributions of the input parameters. Although not presented in this paper, other techniques, such as stratified sampling schemes, may be employed to reduce the number of simulations and, therefore, computer time required (McKay et al., 1979) . It should be noted that for simplicity of illustration, the results of only five simulations are presented in Appendix D.
Statistical analysis of urinary phenol concentrations.
Analysis of the urinary metabolite concentrations is performed using standard methods based on normal theory via the Minitab software program. Normality of the simulation results as well as the distributions produced by the random number generator are statistically assessed using normal probability plot correlation proposed by Filliben (1975) .
RESULTS AND DISCUSSION
Invariably, mathematical models are summarized by process parameters such as rate constants, flows, and equilibrium coefficients. Whether these models are biologically based or simple abstract descriptions, the associated parameters will have uncertainty associated with their values. Monte Carlo simulation is one way to allow the propagation of uncertainty and/or variability through a model.
In our example, the model output distribution (i.e., urinary phenol concentrations) is not significantly different from a lognormal distribution (p > 0.10) with a geometric mean of 22.3 mg/g creatinine and a geometric standard deviation of 1.97. However, the interindividual variability in the results are to be interpreted with caution. The relatively high geometric standard deviation in urinary phenol concentrations may not be representative of actual population variability due to the lack of constraints on model parameters in our example. A separate set of simulations were performed using parameter distributions which were truncated to remain within physiological constraints (i.e., ±3 standard deviations) (Thomas et al., 1996) . Model simulations of phenol metabolite concentrations at the end-of-shift sampling period using truncated parameters were consistent with experimentally derived values from a variety of occupational studies (Vlasak, 1959; van Haaften and Sie, 1965; Docter and Zielhuis, 1967; Utidjian, 1976) (Fig. 2) .
The advantages of applying uncertainty analysis to a PBPK model can differ with the goals of the individual researcher, but generally focus on several distinct areas. Primarily, the propagation of uncertainty can assist in evaluating the predictive ability of the model. For example, suppose a PBPK/PD model is used to predict cancer risk in a population exposed to pesticides in drinking water. The linearized multistage models currently used by the Environmental Protection Agency may, under some circumstances, estimate the population cancer risk within a factor of 100 to 1000 depending on species and dose route extrapolations. In comparison, a hypothetical PBPK/PD model that has a geometric standard deviation as large as 15 for the uncertainty in predicted cancer risk is probably not going to be considered useful. A comparison of analytical models and PBPK models with respect to cancer prediction is discussed, in detail, by Portier and Kaplan (1989) .
Uncertainty analysis may also be used either to evaluate (Vlasak, 1959; van Haaften and Sie, 1965; Docter and Zielhuis, 1967; Utidjian, 1976) . Urinary concentrations of experimental data points were adjusted for an average creatinine concentration of 1.35 mg/liter (Rosenberg et al., 1989) . The shaded area encloses the first and third quartiles of the 1000 Monte Carlo simulations, while the solid line depicts the median simulation result.
the complexity of a model or to compare two different versions of the same model (Gardner et al., 1980; Woodruff et al., 1992) . For example, greater detail may be added to a PBPK/PD model in order to improve its ability to represent the behavior of a data set. However, the additional complexity added to the model may also increase the uncertainty in model output. Eventually, the trade-off between additional complexity and uncertainty will define which states to aggregate or separate and which processes to include or exclude from the model.
Finally, incorporating uncertainty analysis into PBPK models may help identify processes and/or parameters which need further investigation. Specifically, a PBPK model is a mathematical expression of the animal-chemical system and relies upon our understanding of the functional relations within the system . Validation of the model is an iterative process in which its predictions are compared with experimental data . Within this iterative process, uncertainty analysis can identify which variables contribute most to the uncertainty in model output and, possibly, to alterations in model performance. Therefore, uncertainty analysis is only a small, but necessary, part of the validation process and should serve only as a tool when evaluating the validity, complexity, or predictive ability of PBPK models.
In spite of the importance of variability analysis in the application of PBPK models, two assumptions are typically made when using Monte Carlo simulation. The first assumption concerns the choice of distributions (e.g., normal, lognormal, triangular) that are applied to the model parameters. Although a few model parameters (e.g., body weight) are measured on a large enough portion of the population to provide a reliable estimate of the probability distribution, other model parameters are measured on only relatively small subpopulations which makes assigning distributions difficult. The second assumption is that the input parameters are distributed independently. In a PBPK model, this assumption is not always true and may lead to overestimating the variability in model output. However, relaxation of the assumption of independence would require knowledge-or at least, reliable estimation-of the correlation structure for the input parameters; unfortunately, such information is usually limited. 
